This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Jony van Hilst during the Minimally Invasive Pancreatic Resection: Present and Future on April 13 2018
Keyword(s): abdominal dressing, benign pancreatic tumor, blood loss, conversion, delayed gastric emptying, DGE, DIPLOMA trial, DISPACT 2 trial, Dutch pancreatic cancer group, endpoint, functional recovery, funding, Germany, grant, IDEAL framework, India, Johnson & Johnson, laparoscopic Whipple, LAPOP trial, length of stay, LEOPARD 2 trial, LEOPARD trial, LOS, malignant pancreatic tumor, MIDP, minimally invasive distal pancreatectom, minimally invasive pancreatic resection, minimally invasive Whipple, MIPR, mortality, open distal pancreatectomy, operative time, PADULAP trial, pain control, pancreatic fistula, periampullary tumors, PLOT trial, primary endpoint, primary outcome, randomized controlled trials, RCT, robot, training, trial, WHO, World Health Organization, worldwide survey
Intro–25 sec HPB 2017
IDEAL framework–46 sec Lancet 2009
LEOPARD trial–2:38
DIPLOMA trial–6:00
PLOT trial–7:30 Br J Surg 2017
Conclusion–9:40